破坏的线粒体质量控制网络:化学疗法诱导的多器官毒性治疗的统一机制和治疗目标
Yaling Li1,2, Ningning Ding3, Xiufan Liu3
1Gansu University Key Laboratory for Molecular Medicine & Chinese Medicine Prevention and Treatment of Major Diseases, Gansu University of Chinese Medicine, Lanzhou 730000, China.
化疗通过破坏线粒体质量控制 (MQC) 网络而导致器官损伤. 针对MQC途径可能会降低毒性并改善癌症患者的治疗结果.
科学领域:
- 线粒体生物学 线粒体生物学
- 癌症治疗方法 癌症治疗方法
- 毒理学 毒理学 毒理学
背景情况:
- 化疗对于癌症治疗至关重要,但在40-80%的患者中会导致严重的器官毒性 (心脏毒性,神经毒性,毒性).
- 这些毒性导致治疗中断和长期死亡率增加.
- 提出了一种涉及破坏线粒体质量控制 (MQC) 网络的统一机制.
研究的目的:
- 审查MQC网络中断在化疗引起的器官毒性的作用.
- 在MQC网络中确定可用药物的目标,以减轻这些毒性.
- 提出一个框架来制定有针对性的干预措施.
主要方法:
- 对MQC途径 (生物发生,动力学,线粒细胞衰变,蛋白质稳定,线粒细胞衰变) 和化疗效应的现有文献的综述.
- 分析常见的化疗药物 (人环素,剂,税) 如何影响MQC模块.
- 列出针对MQC检查点的潜在治疗干预措施.
主要成果:
- 化疗药物通过抑制PGC-1α,过度激活Drp1裂变,损害自菌体-溶酶体融合,并抑制线粒细胞分裂来破坏MQC.
- 这种干扰导致线粒体功能障碍,反应性氧物种 (ROS) 溢出和细胞死亡.
- 确定drp1过度激活,线粒 arrest和线粒细胞抑制是关键的治疗节点.
结论:
- 针对MQC中断提供了一种策略,可以将抗癌疗效与器官毒性分开.
- 恢复MQC检查点的干预措施可以优化剂量,减少治疗中止,改善患者的预后.
- 大多数针对MQC的药物目前正在临床前或早期临床试验中.
更多相关视频
08:43Rat Model of Blood-brain Barrier Disruption to Allow Targeted Neurovascular Therapeutics
Published on: November 30, 2012
05:45Developmental Toxicity Assay Based on Real-Time Monitoring of Fibroblast Growth Factor Signal Disruption in Human Induced Pluripotent Stem Cells
Published on: October 10, 2025
相关概念视频
Quality Control
Quality control helps track data, visualize trends, and identify variations, making it easier to detect deviations that may affect the accuracy of an analysis. One way to do this is by generating a quality control chart, which...
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
Two synthetic agonists of THC,...
Protein Networks
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
Phenothiazines, such as prochlorperazine...
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
